Protocol Ledger

NCT05233397 · Phase II · RECRUITING

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Interventional Phase II clinical trial protocol NCT05233397 sponsored by Nationwide Children's Hospital in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2022-12-16 Enrollment: 30 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05233397
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)30 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05233397
Protocol FieldVerified Registry Value
NCT IdentifierNCT05233397
Consolidated Lead SponsorNationwide Children's Hospital
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment30 participants (ESTIMATED)
Registered Start Date2022-12-16
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI